Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01862276

Enrollment

200

Registered

2013-05-24

Start date

2013-03-31

Completion date

2014-03-31

Last updated

2014-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrahepatic Cholangiocarcinoma

Brief summary

To investigate the prognosis due to presence or absence of bile duct resection in intrahepatic cholangiocarcinoma that require hepatic lobectomy.

Detailed description

The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type, is still controversial. We retrospectively evaluated the effect of bile duct resection in this surgery.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Cases of major hepatectomy due to intrahepatic cholangiocarcinoma

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
3-year recurrence-free survival rate	11 years (2000-2010)
Ratio of local recurrence at the hepatico-duodenal ligament	11 years

Countries

Japan

Outcome results